Dorr RT, Paxinos J: The current status of laetrile. Ann Intern Med 89
(3): 389-97, 1978.
Viehoever A,
Mack H: Bio-chemistry of amygdalin (bitter, cyanogenetic
principle from bitter almonds). Am J Pharm 107 (Oct): 397-450, 1935.
The laetrile controversy. In: Moss RW: The Cancer Industry: The Classic
Expose on the Cancer Establishment. Brooklyn, NY: First Equinox Press,
1996, pp 131-52.
Laetrile at Sloan-Kettering: a case study. In: Moss RW: The Cancer
Industry: The Classic Expose on the Cancer Establishment. Brooklyn, NY:
First Equinox Press, 1996, pp 153-86.
Curt GA: Unsound methods of cancer treatment. Princ Pract Oncol Updates 4
(12): 1-10, 1990.
Fenselau C, Pallante S, Batzinger RP, et al.: Mandelonitrile
beta-glucuronide: synthesis and characterization. Science 198 (4317):
625-7, 1977.
Chandler RF, Anderson LA, Phillipson JD: Laetrile in perspective. Can
Pharm J 117 (11): 517-20, 1984.
Newmark J, Brady RO, Grimley PM, et al.: Amygdalin (Laetrile) and
prunasin beta-glucosidases: distribution in germ-free rat and in human
tumor tissue. Proc Natl Acad Sci U S A 78 (10): 6513-6, 1981.
Rauws AG, Olling M, Timmerman A: The pharmacokinetics of prunasin, a
metabolite of amygdalin. J Toxicol Clin Toxicol 19 (8): 851-6, 1982.
Ross WE: Unconventional cancer therapy. Compr Ther 11 (9): 37-43, 1985.
Ames MM, Moyer TP, Kovach JS, et al.: Pharmacology of amygdalin
(laetrile) in cancer patients. Cancer Chemother Pharmacol 6 (1): 51-7,
1981.
Krebs ET Jr, Krebs ET Sr, Beard HH: The unitarian or trophoblastic
thesis of cancer. Med Rec 163 (7): 149-74, 1950.
Ellison NM: Unproven methods of cancer therapy. Drug Ther (NY) 10(July):
73-82, 1980.
Navarro MD: The Philippine experience in the early detection and
chemotherapy of cancer. St Tomas J Med 25 (3): 125-33, 1970.
Greenberg DM: The case against laetrile: the fraudulent cancer remedy.
Cancer 45 (4): 799-807, 1980.
Levi L, French WN, Bickis IJ, et al.: Laetrile: a study of its
physicochemical and biochemical properties. Can Med Assoc J 92 (20):
1057-61, 1965.
Treatment of cancer with laetriles; a report by the Cancer Commission of
the California Medical Association. Calif Med 78 (4): 320-6, 1953.
Unproven methods of cancer management. Laetrile. CA Cancer J Clin 22
(4): 245-50, 1972 Jul-Aug.
Navarro MD: Five years experience with laetrile therapy in advanced
cancer. Acta Unio Int Contr Cancrum 15(suppl 1): 209-21, 1959.
Morrone JA: Chemotherapy of inoperable cancer: preliminary report of 10
cases treated with laetrile. Exp Med Surg 20: 299-308, 1962.
Chen X, Wu B, Wang PG: Glucuronides in anti-cancer therapy. Curr Med
Chem Anticancer Agents 3 (2): 139-50, 2003.
GAL EM, FUNG FH, GREENBERG DM: Studies on the biological action of
malononitriles. II. Distribution of rhodanese (transulfurase) in the
tissues of normal and tumor-bearing animals and the effect of
malononitriles thereon. Cancer Res 12 (8): 574-9, 1952.
Sabelli R, Iorio E, De Martino A, et al.: Rhodanese-thioredoxin system
and allyl sulfur compounds. FEBS J 275 (15): 3884-99, 2008.
Herbert V: Laetrile: the cult of cyanide. Promoting poison for profit.
Am J Clin Nutr 32 (5): 1121-58, 1979.
Scott PJ: Laetrile and cancer quackery problems. Cancer Forum 5 (2):
93-97, 1981.
Cheng H, Cao X, Xian M, et al.: Synthesis and enzyme-specific activation
of carbohydrate-geldanamycin conjugates with potent anticancer
activity. J Med Chem 48 (2): 645-52, 2005.
Bernacki RJ, Niedbala MJ, Korytnyk W: Glycosidases in cancer and
invasion. Cancer Metastasis Rev 4 (1): 81-101, 1985.
Lerner IJ: Laetrile: a lesson in cancer quackery. CA Cancer J Clin 31
(2): 91-5, 1981 Mar-Apr.
Lerner IJ: The whys of cancer quackery. Cancer 53 (3 Suppl): 815-9,
1984.
Shils ME, Hermann MG: Unproved dietary claims in the treatment of
patients with cancer. Bull N Y Acad Med 58 (3): 323-40, 1982.
Young VR, Newberne PM: Vitamins and cancer prevention: issues and
dilemmas. Cancer 47 (5 Suppl): 1226-40, 1981.
Jukes TH: Is laetrile a vitamin? Nutr Today 12 (5): 12-17, 1977.
Aucun commentaire:
Enregistrer un commentaire